Sustainable Early Episode Clinic Study (SEEC) (NCT03571685) | Clinical Trial Compass
CompletedNot Applicable
Sustainable Early Episode Clinic Study (SEEC)
United States50 participantsStarted 2017-01-31
Plain-language summary
The purpose of this study is to describe relapse rates among participants receiving services in the SEEC program high intensity resource use. For purposes of this study, relapse will be defined as: Psychiatric hospitalization; Psychiatric emergency department visits; Ambulatory acute services (Partial Hospitalization Program, Intensive Outpatient Program, Crisis House stay).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria - Participants
* Participants must be at least 18 years or older
* Participants within 5 years of a clinical diagnosis of Schizophrenia or Schizoaffective disorder made by a clinician with understanding of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for these disorders
* Participants must be able to speak, read, and understand English
* Participants must sign an informed consent form
Inclusion Criteria - Caregivers
* Caregivers must be 18 years or older Caregivers must also be willing to attend the multi-family psychoeducation group series (Phase I)
* Caregivers must be willing to participate in monthly family therapy and/or monthly phone contact with staff for the duration of the study
* Caregivers must sign informed consent form
Exclusion Criteria - Participants
* Co-occurring developmental disabilities
* Receiving electroconvulsive therapy
* Primary substance use disorder
* On permanent conservatorship
* Unable to complete baseline assessments due to acuity of psychiatric symptoms
Exclusion Criteria - Caregivers
* Caregivers who refuse to participate in the psychoeducation series of Phase 1
* Caregivers who refuse monthly family therapy/phone contact with staff will be excluded
* Caregiver is mentally or physically incapable of adequately performing the required study procedures, as determined by treatment team
* Caregiver is an employee of the investigator or study site, with direct involvement in the…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.